PMID- 35667438 OWN - NLM STAT- MEDLINE DCOM- 20220726 LR - 20220728 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 298 IP - 7 DP - 2022 Jul TI - Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding. PG - 102100 LID - S0021-9258(22)00541-5 [pii] LID - 10.1016/j.jbc.2022.102100 [doi] LID - 102100 AB - Rhesus monkeys have evolved MHC-encoded class I allomorphs such as Mamu-B *098 that are capable of binding N-myristoylated short lipopeptides rather than conventional long peptides; however, it remains unknown whether such antigen-binding molecules exist in other species, including humans. We herein demonstrate that human leukocyte antigen (HLA)-A *24:02 and HLA-C *14:02 proteins, which are known to bind conventional long peptides, also have the potential to bind N-myristoylated short lipopeptides. These HLA class I molecules shared a serine at position 9 (Ser9) with Mamu-B *098, in contrast to most MHC class I molecules that harbor a larger amino acid residue, such as tyrosine, at this position. High resolution X-ray crystallographic analyses of lipopeptide-bound HLA-A *24:02 and HLA-C *14:02 complexes indicated that Ser9 was at the bottom of the B pocket with its small hydroxymethyl side chain directed away from the B-pocket cavity, thereby contributing to the formation of a deep hydrophobic cavity suitable for accommodating the long-chain fatty acid moiety of lipopeptide ligands. Upon peptide binding, however, we found the hydrogen-bond network involving Ser9 was reorganized, and the remodeled B pocket was able to capture the second amino acid residue (P2) of peptide ligands. Apart from the B pocket, virtually no marked alterations were observed for the A and F pockets upon peptide and lipopeptide binding. Thus, we concluded that the structural flexibility of the large B pocket of HLA-A *2402 and HLA-C *1402 primarily accounted for their previously unrecognized capacity to bind such chemically distinct ligands as conventional peptides and N-myristoylated lipopeptides. CI - Copyright (c) 2022 The Authors. Published by Elsevier Inc. All rights reserved. FAU - Asa, Minori AU - Asa M AD - Laboratory of Cell Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan; Laboratory of Cell Regulation and Molecular Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan. FAU - Morita, Daisuke AU - Morita D AD - Laboratory of Cell Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan; Laboratory of Cell Regulation and Molecular Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan. FAU - Kuroha, Jin AU - Kuroha J AD - Laboratory of Cell Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan; Laboratory of Cell Regulation and Molecular Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan. FAU - Mizutani, Tatsuaki AU - Mizutani T AD - Laboratory of Cell Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan; Laboratory of Cell Regulation and Molecular Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan. FAU - Mori, Naoki AU - Mori N AD - Laboratory of Chemical Ecology, Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan. FAU - Mikami, Bunzo AU - Mikami B AD - Laboratory of Applied Structural Biology, Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan. FAU - Sugita, Masahiko AU - Sugita M AD - Laboratory of Cell Regulation, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan; Laboratory of Cell Regulation and Molecular Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan. Electronic address: msugita@infront.kyoto-u.ac.jp. LA - eng PT - Journal Article DEP - 20220603 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Amino Acids) RN - 0 (HLA-A*24:02 antigen) RN - 0 (HLA-A24 Antigen) RN - 0 (HLA-C Antigens) RN - 0 (HLA-C*14 antigen) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Ligands) RN - 0 (Lipopeptides) SB - IM MH - Amino Acids/chemistry MH - *HLA-A24 Antigen/chemistry MH - *HLA-C Antigens/chemistry MH - Histocompatibility Antigens Class I/chemistry MH - Humans MH - Ligands MH - *Lipopeptides MH - Protein Binding PMC - PMC9243169 OTO - NOTNLM OT - antigen presentation OT - crystal structure OT - human OT - immunology OT - protein myristoylation COIS- Conflict of interest The authors declare that they have no conflicts of interest regarding the contents of this article. EDAT- 2022/06/07 06:00 MHDA- 2022/07/27 06:00 PMCR- 2022/06/03 CRDT- 2022/06/06 19:23 PHST- 2022/04/05 00:00 [received] PHST- 2022/05/31 00:00 [revised] PHST- 2022/06/01 00:00 [accepted] PHST- 2022/06/07 06:00 [pubmed] PHST- 2022/07/27 06:00 [medline] PHST- 2022/06/06 19:23 [entrez] PHST- 2022/06/03 00:00 [pmc-release] AID - S0021-9258(22)00541-5 [pii] AID - 102100 [pii] AID - 10.1016/j.jbc.2022.102100 [doi] PST - ppublish SO - J Biol Chem. 2022 Jul;298(7):102100. doi: 10.1016/j.jbc.2022.102100. Epub 2022 Jun 3.